NEUTRAGEL

NEUTRAGEL

Marketed by: Schering Oy
Active ingredient: Methylcellulosum,Aluminii hydroxidum gel. siccatum
Other information: oral liquid

Available in: Finland
Language: English
Source: Fimea

NEUTRAGEL COMP

NEUTRAGEL COMP

Marketed by: STAR
Active ingredient: Methylcellulosum,Aluminii hydroxidum gel. siccatum,Magnesii hydroxidum
Other information: oral liquid

Available in: Finland
Language: English
Source: Fimea

NEUTRAGEL COMP

NEUTRAGEL COMP

Marketed by: LEIRAS
Active ingredient: Aluminii hydroxidum gel. siccatum,Methylcellulosum,Magnesii hydroxidum
Other information: tablet

Available in: Finland
Language: English
Source: Fimea

NOVALUZID

NOVALUZID

Marketed by: Hässle Läkemedel AB
Active ingredient: Magnesii hydroxidum-magnesii carbonas,Aluminii hydroxidum
Other information: oral liquid

Available in: Finland
Language: English
Source: Fimea

NOVALUZID

NOVALUZID

Marketed by: Hässle Läkemedel AB
Active ingredient: Aluminii hydroxidum,Magnesii hydroxidum-magnesii carbonas
Other information: chewable tablet

Available in: Finland
Language: English
Source: Fimea

NEUTRAGEL FORTE

NEUTRAGEL FORTE

Marketed by: Schering Oy
Active ingredient: Aluminii hydroxidum gel. siccatum,Magnesii hydroxidum,Aluminii hydroxidum-magnesii carbonas gel.
Other information: oral liquid

Available in: Finland
Language: English
Source: Fimea

NOVALUZID MINT

NOVALUZID MINT

Marketed by: Hässle Läkemedel AB
Active ingredient: Aluminii hydroxidum-magnesii carbonas gel.
Other information: chewable tablet

Available in: Finland
Language: English
Source: Fimea

NOVALUZID MINT

NOVALUZID MINT

Marketed by: AstraZeneca Oy
Active ingredient: Aluminii hydroxidum-magnesii carbonas gel.
Other information: chewable tablet

Available in: Finland
Language: English
Source: Fimea

NOVALUZID

NOVALUZID

Marketed by: Meda Oy
Active ingredient: Aluminii hydroxidum,Magnesii hydroxidum-magnesii carbonas
Other information: oral suspension

Available in: Finland
Language: English
Source: Fimea

NATR BICARBONAS

NATR BICARBONAS

Marketed by: Schering Oy
Active ingredient: Natrii hydrogenocarbonas
Other information: tablet - 1 g

Available in: Finland
Language: English
Source: Fimea

NIZAX

NIZAX

Marketed by: Actavis Nordic A/S
Active ingredient: Nizatidinum
Other information: capsule, hard - 150 mg

Available in: Finland
Language: English
Source: Fimea

NIZAX

NIZAX

Marketed by: Actavis Nordic A/S
Active ingredient: Nizatidinum
Other information: capsule, hard - 300 mg

Available in: Finland
Language: English
Source: Fimea

NITSATIDIINI ENNAPHARMA

NITSATIDIINI ENNAPHARMA

Marketed by: Teva Pharma B.V.
Active ingredient: Nizatidinum
Other information: capsule, hard - 150 mg

Available in: Finland
Language: English
Source: Fimea

NITSATIDIINI ENNAPHARMA

NITSATIDIINI ENNAPHARMA

Marketed by: Teva Pharma B.V.
Active ingredient: Nizatidinum
Other information: capsule, hard - 300 mg

Available in: Finland
Language: English
Source: Fimea

NIZAX

NIZAX

Marketed by: LILLY
Active ingredient: Nizatidinum
Other information: capsule - 150 mg

Available in: Finland
Language: English
Source: Fimea

NIZAX

NIZAX

Marketed by: LILLY
Active ingredient: Nizatidinum
Other information: capsule - 300 mg

Available in: Finland
Language: English
Source: Fimea

NEXIUM

NEXIUM

Marketed by: AstraZeneca Oy
Active ingredient: Esomeprazolum magnesium trihydricum
Other information: gastro-resistant tablet - 20 mg

Available in: Finland
Language: English
Source: Fimea

NEXIUM

NEXIUM

Marketed by: AstraZeneca Oy
Active ingredient: Esomeprazolum magnesium trihydricum
Other information: gastro-resistant tablet - 40 mg

Available in: Finland
Language: English
Source: Fimea

NEXIUM

NEXIUM

Marketed by: AstraZeneca Oy
Active ingredient: Esomeprazolum natricum
Other information: powder for solution for injection/infusion - 40 mg

Available in: Finland
Language: English
Source: Fimea

NEXIUM

NEXIUM

Marketed by: AstraZeneca Oy
Active ingredient: Esomeprazolum magnesium trihydricum
Other information: gastro-resistant granules for oral suspension - 10 mg

Available in: Finland
Language: English
Source: Fimea

NEOPANT

NEOPANT

Marketed by: Orion Oyj
Active ingredient: Isopropamidi bromidum
Other information: tablet - 5 mg

Available in: Finland
Language: English
Source: Fimea

NAVOBAN

NAVOBAN

Marketed by: Novartis Finland Oy
Active ingredient: Tropisetroni hydrochloridum
Other information: solution for injection/concentrate for solution for infusion - 1 mg/ml

Available in: Finland
Language: English
Source: Fimea

NAVOBAN

NAVOBAN

Marketed by: Novartis Finland Oy
Active ingredient: Tropisetroni hydrochloridum
Other information: capsule, hard - 5 mg

Available in: Finland
Language: English
Source: Fimea

NEOMYSIN

NEOMYSIN

Marketed by: Orion Oyj
Active ingredient: Neomycini sulfas
Other information: tablet - 500 mg

Available in: Finland
Language: English
Source: Fimea

NYSTACID

NYSTACID

Marketed by: LÄÄKEFARMOS
Active ingredient: Nystatinum
Other information: tablet - 500000 IU

Available in: Finland
Language: English
Source: Fimea

NUTRIZYM

NUTRIZYM

Marketed by: Merck KGaA
Active ingredient: Bromelaina,Fel tauri,Pancreatinum
Other information: tablet

Available in: Finland
Language: English
Source: Fimea

NAPIRIDE

NAPIRIDE

Marketed by: Medis ehf
Active ingredient: Glimepiridum
Other information: tablet - 1 mg

Available in: Finland
Language: English
Source: Fimea

NAPIRIDE

NAPIRIDE

Marketed by: Medis ehf
Active ingredient: Glimepiridum
Other information: tablet - 2 mg

Available in: Finland
Language: English
Source: Fimea

NAPIRIDE

NAPIRIDE

Marketed by: Medis ehf
Active ingredient: Glimepiridum
Other information: tablet - 3 mg

Available in: Finland
Language: English
Source: Fimea

NAPIRIDE

NAPIRIDE

Marketed by: Medis ehf
Active ingredient: Glimepiridum
Other information: tablet - 4 mg

Available in: Finland
Language: English
Source: Fimea